CODX vs. MUSA

In the year-to-date period, CODX achieves a -65.93% return, which is significantly lower than MUSA's -14.75% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Co-Diagnostics, Inc. (CODX) and Murphy USA Inc. (MUSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CODX Sharpe Ratio is -0.76, which is lower than the MUSA Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of CODX and MUSA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CODX has not paid dividends to shareholders, while MUSA's dividend yield for the trailing twelve months is around 0.45%.

The maximum CODX drawdown since its inception was -99.25%, which is greater than MUSA's maximum drawdown of -33.72%. Use the drawdown chart below to compare losses from any high point for CODX and MUSA.

Co-Diagnostics, Inc. (CODX) has a higher volatility of 28.84% compared to Murphy USA Inc. (MUSA) at 14.55%. This indicates that CODX's price experiences larger fluctuations and is considered to be riskier than MUSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Co-Diagnostics, Inc. and Murphy USA Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.